Newborn screening for Fabry disease in Japan: an additional 3-year report. [PDF]
Sawada T +6 more
europepmc +1 more source
Newborn Screening and Early Cord Blood Transplant for Mucopolysaccharidosis.
Sakaguchi H +18 more
europepmc +1 more source
Real-World Effectiveness and Safety of Eliglustat in Adult Patients with Gaucher Disease Type 1: A Multicenter Retrospective Study in China. [PDF]
Zhou Y, Hao Z, Zhuang Q, Han B.
europepmc +1 more source
Prevalence and sociodemographic, clinical, and genetic characteristics of Fabry disease in north-central Chile, 2013-2023. [PDF]
Royo Martínez S +4 more
europepmc +1 more source
From Lysosomal Storage to Neurodegeneration: Sphingolipid Signaling as a Driver of CNS Pathology and Biomarker Strategy in Neuronopathic Gaucher Disease. [PDF]
Casazza K, Kartha RV, Jarnes JR.
europepmc +1 more source
On-site dissolved-gas analysis and electric-resistivity tomography as new tools to trace CO<sub>2</sub> mineral sequestration in aquifers. [PDF]
Brennwald MS +6 more
europepmc +1 more source
Early Initiation of Enzyme Replacement Therapy in Infantile Onset Pompe Disease Improves Cardiac Outcomes: A Longitudinal Analysis. [PDF]
Cohen JL +6 more
europepmc +1 more source
Cost-Effectiveness of Newborn Screening for Infantile-Onset Pompe Disease in Japan. [PDF]
Konomura K +3 more
europepmc +1 more source
Liver Gene Therapy in Fabry Disease Mice With Low Doses of rAAV2/8 Expressing a Codon-Optimized hGLA cDNA Results in Long-Term Disease Correction. [PDF]
Saxena H +11 more
europepmc +1 more source

